India · Delayed Price · Currency is INR Tata Chemicals Earnings Call Transcripts
Fiscal Year 2026
-
Revenue declined 2% YoY due to subdued global demand and higher costs from geopolitical disruptions, but India showed robust growth and non-soda ash revenue rose 14%. Exceptional charges impacted profitability, while CapEx will focus on maintenance and strategic growth.
-
Q3 FY26 saw subdued global soda ash demand and pricing, with India showing relative strength and the US and UK facing margin pressures. Strategic CAPEX is focused on India and value-added products, while cost control and margin protection remain priorities.
-
Standalone performance in India was strong with significant year-over-year growth in revenue, EBITDA, and profit, while consolidated results were impacted by one-time provisions and lower UK volumes. The company expects stable margins in India, positive turnaround in the UK, and is planning capacity expansions funded by new NCDs.
-
Q1 FY26 delivered stable revenues and improved profitability, driven by higher volumes, cost efficiencies, and lower input costs, despite flat global demand and oversupplied markets. Outlook for FY26 remains positive with targeted EBITDA improvements and ongoing capacity expansions.
Fiscal Year 2025
-
Global demand for soda ash grew, but pricing and export margins remain under pressure due to increased supply and tariff uncertainties. India and Kenya are expected to drive growth, while U.K. and U.S. segments focus on restructuring and cost efficiency. FY 2025 saw strong capacity additions and high CapEx, with a cautious outlook for margin recovery.
-
Revenue declined 4% year-over-year due to pricing pressure, but India and U.S. volumes grew. CapEx will be phased to match cash flows, and the U.K. soda ash plant ceased operations with a one-time charge. Market prices are expected to remain low for the next 3–6 months.
-
Q2 FY25 saw 6% sequential revenue growth, driven by U.S. volumes, while Indian operations were impacted by heavy rains but have now stabilized. Major capacity expansions in India, U.S., and Kenya are on track, with a positive long-term demand outlook and margin recovery expected.
-
Stable demand and balanced supply supported operational performance, with India and the U.S. showing margin improvements due to lower costs and steady production. Capacity expansions in soda ash, sodium bicarbonate, and pharmaceutical salt are set to boost EBITDA by INR 400 crore annually.